A new drug has been recently approved for insomnia. Suvorexant tablets (marketed as Belsomra), works on a different pathway than traditional sedatives and you will likely see a blast of TV advertisements.
But is it really so different? Yes and no - it does work on different pathways so may be effective in people in whom previous drugs did not work well. However it has many of the similar issues of existing medications.
It may lead to dependence so that you cannot fall asleep without it. In addition, it carries a risk for behaviors such as driving, eating, having sex, and making phone calls while not fully awake.
It may be marketed as "a new approach", which it is, but it really is not that different.
No comments:
Post a Comment